Jefferies Financial Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-66,500
| Closed | -$2.62M | – | 1491 |
|
|
2024
Q3 | $2.62M | Sell |
66,500
-2,500
| -4% | -$98.4K | 0.02% | 349 |
|
|
2024
Q2 | $2.69M | Buy |
69,000
+3,363
| +5% | +$131K | 0.03% | 334 |
|
|
2024
Q1 | $2.83M | Sell |
65,637
-1,086
| -2% | -$46.8K | 0.03% | 324 |
|
|
2023
Q4 | $3.07M | Buy |
66,723
+55,635
| +502% | +$2.56M | 0.02% | 341 |
|
|
2023
Q3 | $379K | Buy |
11,088
+2,319
| +26% | +$79.2K | ﹤0.01% | 783 |
|
|
2023
Q2 | $338K | Buy |
+8,769
| New | +$338K | ﹤0.01% | 874 |
|
|
2023
Q1 | – | Sell |
-19,500
| Closed | -$769K | – | 1438 |
|
|
2022
Q4 | $769K | Buy |
+19,500
| New | +$769K | 0.01% | 560 |
|